Global Nuclear Medicine Therapy Market Research Report 2023

Nuclear Medicine Therapy Market

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nuclear Medicine Therapy market research.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nuclear Medicine Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Nuclear Medicine Therapy Market Report

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nuclear Medicine Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Radium-223

1.2.3 Lutetium-177

1.2.4 Iodine-131

1.2.5 Other

1.3 Market by Application

1.3.1 Global Nuclear Medicine Therapy Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Thyroid

1.3.3 Bone Metastasis

1.3.4 Lymphoma

1.3.5 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Nuclear Medicine Therapy Market Perspective (2018-2029)

2.2 Nuclear Medicine Therapy Growth Trends by Region

2.2.1 Global Nuclear Medicine Therapy Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Nuclear Medicine Therapy Historic Market Size by Region (2018-2023)

2.2.3 Nuclear Medicine Therapy Forecasted Market Size by Region (2024-2029)

2.3 Nuclear Medicine Therapy Market Dynamics

2.3.1 Nuclear Medicine Therapy Industry Trends

2.3.2 Nuclear Medicine Therapy Market Drivers

2.3.3 Nuclear Medicine Therapy Market Challenges

2.3.4 Nuclear Medicine Therapy Market Restraints

3.1 Global Top Nuclear Medicine Therapy Players by Revenue

3.1.1 Global Top Nuclear Medicine Therapy Players by Revenue (2018-2023)

3.1.2 Global Nuclear Medicine Therapy Revenue Market Share by Players (2018-2023)

3.2 Global Nuclear Medicine Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Nuclear Medicine Therapy Revenue

3.4 Global Nuclear Medicine Therapy Market Concentration Ratio

3.4.1 Global Nuclear Medicine Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Therapy Revenue in 2022

3.5 Nuclear Medicine Therapy Key Players Head office and Area Served

3.6 Key Players Nuclear Medicine Therapy Product Solution and Service

3.7 Date of Enter into Nuclear Medicine Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Nuclear Medicine Therapy Historic Market Size by Type (2018-2023)

4.2 Global Nuclear Medicine Therapy Forecasted Market Size by Type (2024-2029)

5.1 Global Nuclear Medicine Therapy Historic Market Size by Application (2018-2023)

5.2 Global Nuclear Medicine Therapy Forecasted Market Size by Application (2024-2029)

6.1 North America Nuclear Medicine Therapy Market Size (2018-2029)

6.2 North America Nuclear Medicine Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Nuclear Medicine Therapy Market Size by Country (2018-2023)

6.4 North America Nuclear Medicine Therapy Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Nuclear Medicine Therapy Market Size (2018-2029)

7.2 Europe Nuclear Medicine Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Nuclear Medicine Therapy Market Size by Country (2018-2023)

7.4 Europe Nuclear Medicine Therapy Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Nuclear Medicine Therapy Market Size (2018-2029)

8.2 Asia-Pacific Nuclear Medicine Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Nuclear Medicine Therapy Market Size by Region (2018-2023)

8.4 Asia-Pacific Nuclear Medicine Therapy Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Nuclear Medicine Therapy Market Size (2018-2029)

9.2 Latin America Nuclear Medicine Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Nuclear Medicine Therapy Market Size by Country (2018-2023)

9.4 Latin America Nuclear Medicine Therapy Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Nuclear Medicine Therapy Market Size (2018-2029)

10.2 Middle East & Africa Nuclear Medicine Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Nuclear Medicine Therapy Market Size by Country (2018-2023)

10.4 Middle East & Africa Nuclear Medicine Therapy Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Bayer

11.1.1 Bayer Company Detail

11.1.2 Bayer Business Overview

11.1.3 Bayer Nuclear Medicine Therapy Introduction

11.1.4 Bayer Revenue in Nuclear Medicine Therapy Business (2018-2023)

11.1.5 Bayer Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Nuclear Medicine Therapy Introduction

11.2.4 Novartis Revenue in Nuclear Medicine Therapy Business (2018-2023)

11.2.5 Novartis Recent Development

11.3 China Isotope & Radiation

11.3.1 China Isotope & Radiation Company Detail

11.3.2 China Isotope & Radiation Business Overview

11.3.3 China Isotope & Radiation Nuclear Medicine Therapy Introduction

11.3.4 China Isotope & Radiation Revenue in Nuclear Medicine Therapy Business (2018-2023)

11.3.5 China Isotope & Radiation Recent Development

11.4 Dongcheng

11.4.1 Dongcheng Company Detail

11.4.2 Dongcheng Business Overview

11.4.3 Dongcheng Nuclear Medicine Therapy Introduction

11.4.4 Dongcheng Revenue in Nuclear Medicine Therapy Business (2018-2023)

11.4.5 Dongcheng Recent Development

11.5 Q BioMed

11.5.1 Q BioMed Company Detail

11.5.2 Q BioMed Business Overview

11.5.3 Q BioMed Nuclear Medicine Therapy Introduction

11.5.4 Q BioMed Revenue in Nuclear Medicine Therapy Business (2018-2023)

11.5.5 Q BioMed Recent Development

11.6 Curium Pharmaceuticals

11.6.1 Curium Pharmaceuticals Company Detail

11.6.2 Curium Pharmaceuticals Business Overview

11.6.3 Curium Pharmaceuticals Nuclear Medicine Therapy Introduction

11.6.4 Curium Pharmaceuticals Revenue in Nuclear Medicine Therapy Business (2018-2023)

11.6.5 Curium Pharmaceuticals Recent Development

11.7 Jubilant Radiopharma

11.7.1 Jubilant Radiopharma Company Detail

11.7.2 Jubilant Radiopharma Business Overview

11.7.3 Jubilant Radiopharma Nuclear Medicine Therapy Introduction

11.7.4 Jubilant Radiopharma Revenue in Nuclear Medicine Therapy Business (2018-2023)

11.7.5 Jubilant Radiopharma Recent Development

11.8 Lantheus

11.8.1 Lantheus Company Detail

11.8.2 Lantheus Business Overview

11.8.3 Lantheus Nuclear Medicine Therapy Introduction

11.8.4 Lantheus Revenue in Nuclear Medicine Therapy Business (2018-2023)

11.8.5 Lantheus Recent Development

11.9 Aurobindo Pharma

11.9.1 Aurobindo Pharma Company Detail

11.9.2 Aurobindo Pharma Business Overview

11.9.3 Aurobindo Pharma Nuclear Medicine Therapy Introduction

11.9.4 Aurobindo Pharma Revenue in Nuclear Medicine Therapy Business (2018-2023)

11.9.5 Aurobindo Pharma Recent Development

11.10 International Isotopes

11.10.1 International Isotopes Company Detail

11.10.2 International Isotopes Business Overview

11.10.3 International Isotopes Nuclear Medicine Therapy Introduction

11.10.4 International Isotopes Revenue in Nuclear Medicine Therapy Business (2018-2023)

11.10.5 International Isotopes Recent Development

11.11 Mundipharma

11.11.1 Mundipharma Company Detail

11.11.2 Mundipharma Business Overview

11.11.3 Mundipharma Nuclear Medicine Therapy Introduction

11.11.4 Mundipharma Revenue in Nuclear Medicine Therapy Business (2018-2023)

11.11.5 Mundipharma Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Nuclear Medicine Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Radium-223

    Table 3. Key Players of Lutetium-177

    Table 4. Key Players of Iodine-131

    Table 5. Key Players of Other

    Table 6. Global Nuclear Medicine Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Nuclear Medicine Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Nuclear Medicine Therapy Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Nuclear Medicine Therapy Market Share by Region (2018-2023)

    Table 10. Global Nuclear Medicine Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Nuclear Medicine Therapy Market Share by Region (2024-2029)

    Table 12. Nuclear Medicine Therapy Market Trends

    Table 13. Nuclear Medicine Therapy Market Drivers

    Table 14. Nuclear Medicine Therapy Market Challenges

    Table 15. Nuclear Medicine Therapy Market Restraints

    Table 16. Global Nuclear Medicine Therapy Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Nuclear Medicine Therapy Market Share by Players (2018-2023)

    Table 18. Global Top Nuclear Medicine Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Therapy as of 2022)

    Table 19. Ranking of Global Top Nuclear Medicine Therapy Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Nuclear Medicine Therapy Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Nuclear Medicine Therapy Product Solution and Service

    Table 23. Date of Enter into Nuclear Medicine Therapy Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Nuclear Medicine Therapy Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Nuclear Medicine Therapy Revenue Market Share by Type (2018-2023)

    Table 27. Global Nuclear Medicine Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Nuclear Medicine Therapy Revenue Market Share by Type (2024-2029)

    Table 29. Global Nuclear Medicine Therapy Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Nuclear Medicine Therapy Revenue Market Share by Application (2018-2023)

    Table 31. Global Nuclear Medicine Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Nuclear Medicine Therapy Revenue Market Share by Application (2024-2029)

    Table 33. North America Nuclear Medicine Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Nuclear Medicine Therapy Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Nuclear Medicine Therapy Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Nuclear Medicine Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Nuclear Medicine Therapy Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Nuclear Medicine Therapy Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Nuclear Medicine Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Nuclear Medicine Therapy Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Nuclear Medicine Therapy Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Nuclear Medicine Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Nuclear Medicine Therapy Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Nuclear Medicine Therapy Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Nuclear Medicine Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Nuclear Medicine Therapy Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Nuclear Medicine Therapy Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Bayer Company Detail

    Table 49. Bayer Business Overview

    Table 50. Bayer Nuclear Medicine Therapy Product

    Table 51. Bayer Revenue in Nuclear Medicine Therapy Business (2018-2023) & (US$ Million)

    Table 52. Bayer Recent Development

    Table 53. Novartis Company Detail

    Table 54. Novartis Business Overview

    Table 55. Novartis Nuclear Medicine Therapy Product

    Table 56. Novartis Revenue in Nuclear Medicine Therapy Business (2018-2023) & (US$ Million)

    Table 57. Novartis Recent Development

    Table 58. China Isotope & Radiation Company Detail

    Table 59. China Isotope & Radiation Business Overview

    Table 60. China Isotope & Radiation Nuclear Medicine Therapy Product

    Table 61. China Isotope & Radiation Revenue in Nuclear Medicine Therapy Business (2018-2023) & (US$ Million)

    Table 62. China Isotope & Radiation Recent Development

    Table 63. Dongcheng Company Detail

    Table 64. Dongcheng Business Overview

    Table 65. Dongcheng Nuclear Medicine Therapy Product

    Table 66. Dongcheng Revenue in Nuclear Medicine Therapy Business (2018-2023) & (US$ Million)

    Table 67. Dongcheng Recent Development

    Table 68. Q BioMed Company Detail

    Table 69. Q BioMed Business Overview

    Table 70. Q BioMed Nuclear Medicine Therapy Product

    Table 71. Q BioMed Revenue in Nuclear Medicine Therapy Business (2018-2023) & (US$ Million)

    Table 72. Q BioMed Recent Development

    Table 73. Curium Pharmaceuticals Company Detail

    Table 74. Curium Pharmaceuticals Business Overview

    Table 75. Curium Pharmaceuticals Nuclear Medicine Therapy Product

    Table 76. Curium Pharmaceuticals Revenue in Nuclear Medicine Therapy Business (2018-2023) & (US$ Million)

    Table 77. Curium Pharmaceuticals Recent Development

    Table 78. Jubilant Radiopharma Company Detail

    Table 79. Jubilant Radiopharma Business Overview

    Table 80. Jubilant Radiopharma Nuclear Medicine Therapy Product

    Table 81. Jubilant Radiopharma Revenue in Nuclear Medicine Therapy Business (2018-2023) & (US$ Million)

    Table 82. Jubilant Radiopharma Recent Development

    Table 83. Lantheus Company Detail

    Table 84. Lantheus Business Overview

    Table 85. Lantheus Nuclear Medicine Therapy Product

    Table 86. Lantheus Revenue in Nuclear Medicine Therapy Business (2018-2023) & (US$ Million)

    Table 87. Lantheus Recent Development

    Table 88. Aurobindo Pharma Company Detail

    Table 89. Aurobindo Pharma Business Overview

    Table 90. Aurobindo Pharma Nuclear Medicine Therapy Product

    Table 91. Aurobindo Pharma Revenue in Nuclear Medicine Therapy Business (2018-2023) & (US$ Million)

    Table 92. Aurobindo Pharma Recent Development

    Table 93. International Isotopes Company Detail

    Table 94. International Isotopes Business Overview

    Table 95. International Isotopes Nuclear Medicine Therapy Product

    Table 96. International Isotopes Revenue in Nuclear Medicine Therapy Business (2018-2023) & (US$ Million)

    Table 97. International Isotopes Recent Development

    Table 98. Mundipharma Company Detail

    Table 99. Mundipharma Business Overview

    Table 100. Mundipharma Nuclear Medicine Therapy Product

    Table 101. Mundipharma Revenue in Nuclear Medicine Therapy Business (2018-2023) & (US$ Million)

    Table 102. Mundipharma Recent Development

    Table 103. Research Programs/Design for This Report

    Table 104. Key Data Information from Secondary Sources

    Table 105. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Nuclear Medicine Therapy Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Nuclear Medicine Therapy Market Share by Type: 2022 VS 2029

    Figure 3. Radium-223 Features

    Figure 4. Lutetium-177 Features

    Figure 5. Iodine-131 Features

    Figure 6. Other Features

    Figure 7. Global Nuclear Medicine Therapy Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Nuclear Medicine Therapy Market Share by Application: 2022 VS 2029

    Figure 9. Thyroid Case Studies

    Figure 10. Bone Metastasis Case Studies

    Figure 11. Lymphoma Case Studies

    Figure 12. Other Case Studies

    Figure 13. Nuclear Medicine Therapy Report Years Considered

    Figure 14. Global Nuclear Medicine Therapy Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Nuclear Medicine Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Nuclear Medicine Therapy Market Share by Region: 2022 VS 2029

    Figure 17. Global Nuclear Medicine Therapy Market Share by Players in 2022

    Figure 18. Global Top Nuclear Medicine Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Therapy as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Nuclear Medicine Therapy Revenue in 2022

    Figure 20. North America Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Nuclear Medicine Therapy Market Share by Country (2018-2029)

    Figure 22. United States Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Nuclear Medicine Therapy Market Share by Country (2018-2029)

    Figure 26. Germany Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Nuclear Medicine Therapy Market Share by Region (2018-2029)

    Figure 34. China Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Nuclear Medicine Therapy Market Share by Country (2018-2029)

    Figure 42. Mexico Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Nuclear Medicine Therapy Market Share by Country (2018-2029)

    Figure 46. Turkey Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Nuclear Medicine Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Bayer Revenue Growth Rate in Nuclear Medicine Therapy Business (2018-2023)

    Figure 49. Novartis Revenue Growth Rate in Nuclear Medicine Therapy Business (2018-2023)

    Figure 50. China Isotope & Radiation Revenue Growth Rate in Nuclear Medicine Therapy Business (2018-2023)

    Figure 51. Dongcheng Revenue Growth Rate in Nuclear Medicine Therapy Business (2018-2023)

    Figure 52. Q BioMed Revenue Growth Rate in Nuclear Medicine Therapy Business (2018-2023)

    Figure 53. Curium Pharmaceuticals Revenue Growth Rate in Nuclear Medicine Therapy Business (2018-2023)

    Figure 54. Jubilant Radiopharma Revenue Growth Rate in Nuclear Medicine Therapy Business (2018-2023)

    Figure 55. Lantheus Revenue Growth Rate in Nuclear Medicine Therapy Business (2018-2023)

    Figure 56. Aurobindo Pharma Revenue Growth Rate in Nuclear Medicine Therapy Business (2018-2023)

    Figure 57. International Isotopes Revenue Growth Rate in Nuclear Medicine Therapy Business (2018-2023)

    Figure 58. Mundipharma Revenue Growth Rate in Nuclear Medicine Therapy Business (2018-2023)

    Figure 59. Bottom-up and Top-down Approaches for This Report

    Figure 60. Data Triangulation

    Figure 61. Key Executives Interviewed